{"nct_id":"NCT06057402","title":"Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-10-03","start_date_type":"ACTUAL","primary_completion_date":"2032-02-22","primary_completion_date_type":"ESTIMATED","completion_date":"2032-02-22","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["PFE"]}